MATN3 and bladder transitional cell carcinoma: The clinical significance of MATN3 expression was further reinforced by our survival analyses, which revealed that higher levels of MATN3 were associated with shorter overall survival in patients with BLCA, CESC, HNSC, LGG, LIHC, MESO, OV, PCPG, and STAD.